Bicheng C. Liu

No. 87 Dingjiaqiao Rd
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 131 publications

Efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis: a multicenter, randomized, open-label, active-controlled, phase III trial.

Efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis: a multicenter, randomized, open-label, active-controlled, phase III trial.

Journal: Renal failure

Published: September 01, 2026

Safety, Pharmacokinetics, and Pharmacodynamics of SHR6508, a Calcium-Sensing Receptor Agonist, in Maintenance Hemodialysis Patients With Secondary Hyperparathyroidism: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Safety, Pharmacokinetics, and Pharmacodynamics of SHR6508, a Calcium-Sensing Receptor Agonist, in Maintenance Hemodialysis Patients With Secondary Hyperparathyroidism: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Journal: Kidney medicine

Published: July 01, 2026

Distinct Motility and Pro-fibrotic effect of Renal Tubule-derived Extracellular Vesicles in Fibrotic Extracellular Matrix.

Distinct Motility and Pro-fibrotic effect of Renal Tubule-derived Extracellular Vesicles in Fibrotic Extracellular Matrix.

Journal: Acta biomaterialia

Published: February 05, 2026

Surface charge engineering shields extracellular vesicles from plasma protein corona to enable systemic extrahepatic targeting.

Surface charge engineering shields extracellular vesicles from plasma protein corona to enable systemic extrahepatic targeting.

Journal: Materials today. Bio

Published: January 24, 2026

Targeting CH25H/25HC-ferroptosis axis: a novel mechanism of MSC-EVs mediated renoprotection in ischemic AKI.

Targeting CH25H/25HC-ferroptosis axis: a novel mechanism of MSC-EVs mediated renoprotection in ischemic AKI.

Journal: Journal of nanobiotechnology

Published: January 22, 2026

Mesenchymal stem cell-derived small extracellular vesicles suppress pyroptosis by delivering miR-125a-5p to improve acute kidney injury in sepsis.

Mesenchymal stem cell-derived small extracellular vesicles suppress pyroptosis by delivering miR-125a-5p to improve acute kidney injury in sepsis.

Journal: Cell death discovery

Published: January 06, 2026

Renal interstitial inflammation predicts IgA nephropathy progression via multiple machine learning models.

Renal interstitial inflammation predicts IgA nephropathy progression via multiple machine learning models.

Journal: Clinical nephrology

Published: December 22, 2025

The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis-Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (Recombinant Human Erythropoietin), Open-Label Study - The ENARODIAL Study.

The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis-Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (Recombinant Human Erythropoietin), Open-Label Study - The ENARODIAL Study.

Journal: American journal of nephrology

Published: October 13, 2025

Asiaticoside attenuates renal fibrosis by targeting STAT3 to restore Th17/Treg homeostasis.

Asiaticoside attenuates renal fibrosis by targeting STAT3 to restore Th17/Treg homeostasis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 25, 2025

ATF4 promotes renal tubulointerstitial fibrosis through hexokinase II-mediated glycolysis.

ATF4 promotes renal tubulointerstitial fibrosis through hexokinase II-mediated glycolysis.

Journal: Frontiers in immunology

Published: August 10, 2025

Uromodulin p.His36Tyr promotes macrophage pyroptosis via App-Cd74 signaling to drive renal inflammation in ADTKD.

Uromodulin p.His36Tyr promotes macrophage pyroptosis via App-Cd74 signaling to drive renal inflammation in ADTKD.

Journal: Nature communications

Published: July 12, 2025

C-INSIGHT: design and methodology of a nationwide registry for high-risk chronic kidney disease in China - a study protocol.

C-INSIGHT: design and methodology of a nationwide registry for high-risk chronic kidney disease in China - a study protocol.

Journal: BMC nephrology

Published: July 11, 2025

Showing 1-12 of 131

Last Updated: 09/26/2026